Bloomberg Television
@markets·3.2M subscribers·95.6K videos
How J&J's CFO Keeps His Footing on the 'Patent Cliff'
Posted
September 12, 2024
Views
632
Likes
5
Comments
1
Engagement
September 12, 2024
632
5
1
0.95%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Episode Timeline
Every episode in order around the one you’re watching — click any card and the page flips straight to it.
3:16Now PlayingBetween 2024 and 2030, the largest US pharma companies will lose patent protections on drugs that now account for $180 billion in sales. Johnson & Johnson has $15 billion in sales at risk of erosion. On Bloomberg Chief Future Officer, J&J CFO Joe Wolk and CEO Joaquin Duato tell David Gura how the company aims to renew its portfolio through research and development and strategic acquisition.
--------
More on Bloomberg Television and Markets
Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance
Visit for business news & analysis, uptotheminute market data, features, profiles and more.
Connect with Bloomberg Television on:
Connect with Bloomberg Business on:
More from Bloomberg:
Bloomberg Radio
Bloomberg Surveillance
Bloomberg Politics
Bloomberg Originals
Watch more on YouTube:
Bloomberg Technology
Bloomberg Originals
Bloomberg Quicktake
Bloomberg Espanol
Bloomberg Podcasts
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
